Yuanfei Shi

No. 79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

HAMP, G6PD, and CCL18 as Potential Molecular Markers to Guide Treatment Decisions in Anti-PD-1/PD-L1 Immunotherapy for Hepatocellular Carcinoma.

HAMP, G6PD, and CCL18 as Potential Molecular Markers to Guide Treatment Decisions in Anti-PD-1/PD-L1 Immunotherapy for Hepatocellular Carcinoma.

Journal: Current medicinal chemistry

Published: February 27, 2026

Combined prognostic impact of complex karyotype and KIT mutations refines risk stratification in t(8;21) acute myeloid leukemia.

Combined prognostic impact of complex karyotype and KIT mutations refines risk stratification in t(8;21) acute myeloid leukemia.

Journal: Cancer

Published: November 25, 2025

Effects and molecular mechanism of inhibiting p53 signaling pathway by NSUN4 on the resistance to BCL-2 inhibitor for diffuse large B-cell lymphoma.

Effects and molecular mechanism of inhibiting p53 signaling pathway by NSUN4 on the resistance to BCL-2 inhibitor for diffuse large B-cell lymphoma.

Journal: Clinical and experimental medicine

Published: October 28, 2025

Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?

Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?

Journal: Annals of hematology

Published: October 22, 2025

Global, regional, and national burden of lymphoma from 1990 to 2021: a comprehensive analysis based on the global burden of disease study 1990-2021.

Global, regional, and national burden of lymphoma from 1990 to 2021: a comprehensive analysis based on the global burden of disease study 1990-2021.

Journal: European journal of medical research

Published: September 25, 2025

Exploration of biomarkers for predicting the prognosis of patients with diffuse large B-cell lymphoma by machine-learning analysis.

Exploration of biomarkers for predicting the prognosis of patients with diffuse large B-cell lymphoma by machine-learning analysis.

Journal: BMC immunology

Published: January 22, 2025

A continuously efficient O2-supplying strategy for long-term modulation of hypoxic tumor microenvironment to enhance long-acting radionuclides internal therapy.

A continuously efficient O2-supplying strategy for long-term modulation of hypoxic tumor microenvironment to enhance long-acting radionuclides internal therapy.

Journal: Journal of nanobiotechnology

Published: November 18, 2023

Advances in biology, diagnosis and treatment of DLBCL.

Advances in biology, diagnosis and treatment of DLBCL.

Journal: Annals of hematology

Published: November 03, 2023

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients.

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients.

Journal: Frontiers in oncology

Published: February 23, 2023

Global disease burden and trends of leukemia attributable to occupational risk from 1990 to 2019: An observational trend study.

Global disease burden and trends of leukemia attributable to occupational risk from 1990 to 2019: An observational trend study.

Journal: Frontiers in public health

Published: August 10, 2022

Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia.

Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia.

Journal: Journal of oncology

Published: June 07, 2022

Inhibition of VEGFR2 overcomes venetoclax-resistance in diffuse large B-cell lymphoma cells.

Inhibition of VEGFR2 overcomes venetoclax-resistance in diffuse large B-cell lymphoma cells.

Journal: Genes & diseases

Published: April 22, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026